RxDoctor Payments DataLook up a doctor →

Guy Strauss, DO

Internal Medicine · Lake City, FLNPI 1578570727

Payments from drug & device makers

$13,917,335in general payments, 2019–2025

Across 1,437 payments — averaging $9684.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$7.9M
  • Pfizer$2.9M
  • Abbott$1.7M
  • Biohaven Pharmaceuticals, Inc.$650K
  • AstraZeneca$368K
  • Biohaven Pharmaceutical Holding Company Ltd.$205K
  • plus $223K from 44 others
$12,545in research payments, 2019–2025

Across 3 payments — averaging $4181.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$13K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.376$7,892,337
Pfizer280$2,893,568
Abbott131$1,684,830
Biohaven Pharmaceuticals, Inc.40$650,471
AstraZeneca29$367,973
Biohaven Pharmaceutical Holding Company Ltd.72$204,677
Novavax Inc34$102,400
Teva Pharmaceuticals USA, Inc.14$36,421
Biogen5$22,831
Sanofi US Services Inc.3$22,585
Lexicon Pharmaceuticals, Inc.4$16,524
Astrazeneca UK Limited2$14,517
Amarin Pharma, Inc.15$2,513
Novo Nordisk125$1,187
Novartis40$535
Johnson & Johnson58$530
Amgen(2 entities)38$488
Merck21$337
Lilly USA, LLC18$287
Boehringer Ingelheim15$262
AbbVie14$261
Sanofi-aventis U.S. LLC11$185
GSK11$183
Supernus Pharmaceuticals, Inc.8$141
Astellas Pharma US Inc7$134
Bayer8$128
Mylan Specialty L.p.5$90
Edwards Lifesciences3$85
Vifor Pharma, Inc.4$78
Inspire Medical Systems, Inc.4$76
Esperion Therapeutics, Inc.4$62
Takeda Pharmaceuticals U.S.A., Inc.4$60
Dexcom, Inc.3$60
Corcept Therapeutics3$50
Phathom Pharmaceuticals, Inc.2$44
Sunovion Pharmaceuticals Inc.3$41
Sanofi Pasteur Inc.3$40
E.r. Squibb & Sons, L.L.C.3$39
Insulet Corporation2$38
Lundbeck LLC2$36
Exact Sciences2$35
Jazz Pharmaceuticals Inc.2$33
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$30
Genentech USA, Inc.1$23
Grifols USA, LLC1$21
Nestle Healthcare Nutrition Inc.1$21
Boston Scientific1$20
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$18
CMP Pharma, Inc.1$16
Radius Health, Inc.1$14

How this compares

$13,917,335 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$694,819
Medicare patients
561
Services billed
11,642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Lake City

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →